| 1/5 | US=47 / Câncer Klein C, Vassilev LT. Targeting the p53/MDM2 pathway for cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 19-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO DA VIA P53/MDM2; TERAPIA DE CANCER; PROTEINA P53; MDM2; SUPRESSOR DE TUMOR; INTERACAO PROTEINA-PROTEINA; INTERACAO P53-MDM2 |
| 2/5 | US=58 / Câncer Lee MH, Yeung SCJ, Yang HY. Interplay of 14-3-3 family of proteins with DNA damage-regulated molecules in checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 69-80. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. FAMILIA DE PROTEINAS COM 14-3-3; DANOS AO DNA; RESPOSTA CHECKPOINT; 14-3-3; AKT; MDM2; P53; DANOS NO DNA |
| 3/5 | US=58 / Câncer Post SM, Quinás-Cardama A, Lozano G. Regulation of p53 activity and associated checkpoint controls. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 171-88. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. P53; MDM2; P19; TUMORIGENESE; CANCER; RAS; CICLO CELULAR; RB; CICLINA; CDK |
| 4/5 | US=70 / Biol/Mol Bunz F. Cancer gene pathways. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 173-226. ISBN 978-1-4020-6783-9. CANCER; GENE; VIAS; VIAS CELULARES; INTERACAO PROTEINA-PROTEINA; REACOES BIOQUIMICAS; FOSFORILACAO DE PROTEINAS; SINAIS DA SUPERFICIE CELULAR; TIROSINA-QUINASES PROTEICAS; VIA RAS; FOSFORILACAO DE LIPIDIOS; VIA PI3K/AKT; MORFOGENESE; VIA WNT/APC; HOMEOSTASE; ATIVACAO P53; MDM2; APOPTOSE; CICLO CELULAR |
| 5/5 | US=526 / Tese/FAP Carvalho Filho NP. Análise do status dos genes NMYC, MDM2 e TP53 e da expressão protéica de MDM2, p53 e pRb em pacientes portadores de retinoblastoma submetidos à enucleação. [Status analysis of the genes MYCN, MDM2 and TP53 and protein expression of MDM2, p53 and pRb in patients with retinoblastoma underwent enucleation]. São Paulo, 2015. 70 p. Dissertação(Mestrado)-Fundação Antônio Prudente. Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2015/NeviCarvalhoF/NeviCarvalhoF.pdf RETINOBLASTOMA; PROTEINAS MDM2; PROTEINA P53 SUPRESSORA DE TUMOR; GENES MYC; ENUCLEACAO OCULAR |